Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000549328 | SCV000652625 | uncertain significance | Combined immunodeficiency due to LRBA deficiency | 2023-11-28 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 1695 of the LRBA protein (p.Val1695Ala). This variant is present in population databases (rs200935054, gnomAD 0.1%). This missense change has been observed in individual(s) with common variable immunodeficiency (PMID: 30363934). ClinVar contains an entry for this variant (Variation ID: 473179). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt LRBA protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV000549328 | SCV000897141 | uncertain significance | Combined immunodeficiency due to LRBA deficiency | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV003480683 | SCV004227033 | uncertain significance | not provided | 2022-11-16 | criteria provided, single submitter | clinical testing | BP4 |